Evotec Says JV With Exscientia Starts Human Clinical Trials Of Novel Immuno-oncology Drug

Evotec SE (EVTCY.PK,EVOTF.PK), a German drug discovery alliance and development partnership company, announced Friday that A2a receptor antagonist, which is in development for adult patients with advanced solid tumours, has entered human clinical trials.

The antagonist, co-invented and developed between Evotec and Exscientia, is the most advanced asset arising from the joint venture with Exscientia. It includes application of Exscientia's next generation 3-D evolutionary AI-design platform, Centaur Chemist.

The drug candidate has potential for best-in-class characteristics, with high selectivity for the target receptor, bringing together potential benefits of reduced systemic side effects as well as minimal brain exposure to avoid potential undesired centrally-mediated side effects.

Tumour cells produce high levels of adenosine, a molecule that helps them escape immune system detection by binding to the A2a receptor on cancer-fighting T-cells, reducing T-cell ability to eliminate disease. The highly selective A2a receptor antagonist is being investigated for its ability to prevent adenosine from binding to the T-cell receptor and potentially promote anti-tumour T-cell activity.

Exscientia will lead further clinical development of the molecule and Evotec will retain co-ownership rights throughout clinical development.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
American Airlines canceled hundreds of flights this weekend and plans to cut more through at least mid-July due to bad weather and staffing shortages, multiple reports said. The shortage of flights come as demand is increasing heavily in the United States with reducing coronavirus cases benefited mainly by increased vaccination. Chinese HR firm 51job, Inc. (JOBS) announced Monday that it has entered into a definitive Agreement and Plan of Merger with Garnet Faith Limited, pursuant to which, and subject to the terms and conditions thereof, Garnet Faith will merge with and into 51job, with 51job being the surviving company, in... Priceline, affiliated to Booking Holdings Inc., is launching Fourth of July Freedom sale with bigger savings on flights, hotels and rental cars for the upcoming summer travel season. The company, which offers exclusive discounts on hotels, flights, alternative accommodations, rental cars, cruises and packages, said the two-week Freedom Sale will feature special discounts and promotions.
Follow RTT